Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.
NCT04236960
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Meningococcal Infections
Interventions
BIOLOGICAL:
Meningococcal Group ACYW135 Conjugate Vaccine
Sponsor
Walvax Biotechnology Co., Ltd.